Align Financial’s Medline Inc MDLN Stock Holding History

Align Financial’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$590	Buy	+17	New	+$622	﹤0.01%	456

Other funds holding MDLN

Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Clio Asset Management Charlottesville, Virginia $119M AUM 1.1% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Pictet Bank & Trust Nassau, Bahamas $85.5M AUM 18.48% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Align Financial's MDLN Position: Q3 2026 in Review

Align Financial opened a new position in Medline Inc (MDLN) in Q3 2026: 17 shares worth $590. The stake represents ﹤0.01% of the portfolio and ranks #456 among its holdings.

52 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

Align Financial held 17 shares of Medline Inc worth $590 as of Q3 2026.
Medline Inc was a new Align Financial position in Q3 2026.
Medline Inc made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #456 holding.
52 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.